Senior Director, Business Development at evitria
Mail: rp@evitria.com
Starting at evitria in 2020 as Director of Client Relations, Richard Park has been Senior Director, Business Development at Evitria since 2024. This makes him the interface between clients and the company, specialized in providing service solutions for expression and purification in the antibody production.
Richard Park graduated from Brown University with Bachelor’s degrees in French studies and biomedical engineering, the latter of which he concluded with a thesis on the “Dilutive effects of protein-SDS complexes in microfluidic gel electrophoresis”. Consequently, he has gained broad experience in the biotechnology industry as well as being concerned with civil rights and social actions.
LinkedIn profile: Richard Park
Articles
Glycosylation is an essential biochemical process, which is also used in the production of recombinant proteins. In this article, we will explore it in more detail.
In the course of recombinant antibody production, purification is one of the last, yet most essential steps. Therefore, this article will be concerned with recombinant antibody purification.
The expression of recombinant antibodies has opened entirely new possibilities in life sciences. In this article, we will take a more detailed look at this process.